Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Predictive Oncology Inc
(NQ:
POAI
)
0.9500
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Predictive Oncology Inc
< Previous
1
2
3
4
Next >
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Q2 2024 Financial Results, Provides Business Update
August 14, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update
August 14, 2024
Company to host investor call and webcast today, August 14th, at 8:30am EDT
From
Predictive Oncology Inc.
Via
GlobeNewswire
BioMedNewsBreaks — Predictive Oncology Inc. (NASDAQ: POAI) Announces Expansion of Live-Cell Tumor Platform Applications
August 13, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Predictive Oncology Expands the Application of its Live-Cell Tumor Platform to De-Risk Drug Discovery and Accelerate Pipeline Development
August 13, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
AINewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Schedules Release of Q2 2024 Financial Results, Conference Call
August 07, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024
August 07, 2024
Management to host conference call and webcast at 8:30am ET
From
Predictive Oncology Inc.
Via
GlobeNewswire
AINewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Enters into $1.2M Agreement for Exercise of Warrants
July 26, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds
July 26, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Expands Its AI/ML Driven Platform to Include Novel Oncology Biomarker Discovery
July 25, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results
July 25, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Unveils Novel Technology, Eyes Significant Partnership Opportunities
June 11, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs)
June 11, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Launches Novel Technology to Accelerate Cancer Drug Discovery, Development
June 04, 2024
Via
Investor Brand Network
Topics
Animal Testing
Artificial Intelligence
Exposures
Animal Testing
Artificial Intelligence
Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery
June 04, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) CEO to Participate at Upcoming BIO International Convention 2024
May 29, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024
May 29, 2024
Presentation to highlight Company’s novel application of AI/machine learning capabilities utilizing its proprietary biobank of more than 150,000 tumor samples to guide leading biopharma partners...
From
Predictive Oncology Inc.
Via
GlobeNewswire
TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Positive Results from Ovarian Cancer Study
May 28, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 28, 2024
Study successfully demonstrated Predictive’s ability to build AI multi-omic machine learning models to predict survival outcomes among ovarian cancer patients better than clinical data alone
From
Predictive Oncology Inc.
Via
GlobeNewswire
BioMedNewsBreaks — Predictive Oncology Inc. (NASDAQ: POAI) Announces Q1 2024 Financial Results, Provides Business Update
May 15, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update
May 15, 2024
Company to host investor call and webcast today, May 15th, at 8:30am EDT
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Schedules Release of Q1 2024 Financial Results, Conference Call
May 10, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024
May 10, 2024
Management to host conference call and webcast at 8:30am ET
From
Predictive Oncology Inc.
Via
GlobeNewswire
BioMedNewsBreaks — Predictive Oncology Inc. (NASDAQ: POAI) Partners with FluGen to Develop First-of-Its-Kind Intranasal Flu Vaccine for Global Distribution
May 01, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Predictive Oncology Announces Significant Progress with FluGen In the Development of First-of-Its-Kind Intranasal Flu Vaccine
April 30, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Abstract to Be Presented Next Month at ASCO Annual Meeting
April 25, 2024
Via
Investor Brand Network
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update
March 28, 2024
Company to host investor call and webcast on Monday, April 1st, at 8:30am EDT
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) CEO to Present at Three Upcoming Events
February 22, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Predictive Oncology to Participate in Upcoming Investor Conferences
February 21, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Participation in January Conferences
January 02, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.